Skip to main content

Table 1 Demographic and clinical characteristics of study subjects

From: Correction: The association between dietary quality scores with C-reactive protein and novel biomarkers of inflammation platelet-activating factor and lipoprotein-associated phospholipase A2: a cross-sectional study

Characteristics

Mean ± SD or N (%) or Median (IQR range)

P valuea

Mean ± SD or N (%) or Median (IQR range)

P valuea

Total

n = 100

Male

n = 31

Female

n = 69

High Risk of CVD

n = 68

Low Risk of CVD

n = 32

Age, yearsb

49 ± 13

46 ± 13

50 ± 13

120

53 ± 13

38 ± 14

 < 0.001

Race, Caucasian n (%)

92 (92)

25 (86)

67 (94)

 

65 (96)

27 (84)

 

Male n (%)

    

21 (31)

10 (31)

 

BMI, kg/m2b

28.3 ± 6.5

27.41 ± 5.0

28.65 ± 7.2

0.729

30.65 ± 6.4

23.19 ± 2.7

 < 0.001

Waist Circumference (cm) Umbilicusb

95.8 ± 6.7

95.99 ± 12.60

95.70 ± 18.40

0.526

102.36 ± 15.40

81.83 ± 9.15

 < 0.001

Type 2 Diabetes diagnosis %

4 (4)

3 (10)

1 (1)

–

4 (6)

0 (0)

–

Physical Activity METs tertiles

1.41 ± 0.65

1.61 ± 0.72

1.32 ± 0.83

0.193

1.28 ± . 84

1.69 ± . 65

0.193

n (%) low PA

20 (20)

4 (13)

16 (23)

–

17 (25)

3 (9)

–

n (%) medium PA

19 (19)

4 (13)

15 (22)

–

15 (22)

4 (13)

–

n (%) high PA

61 (61)

23 (74)

38 (55)

–

36 (53)

25 (78)

–

PAF ng/mLb

7.96 (3.89–16.77)

9.95 (4.31–15.33)

6.45 (3.81–18.90)

0.814

4.84 (3.24–14.57)

13.27 (9.59–21.63)

 < 0.001

Lp-PLA2 nmol/min/mL

14.91 ± 4.29

16.98 ± 4.90

13.98 ± 3.65

 < 0.001

15.30 ± 4.42

14.09 ± 3.94

0.19

hsCRP mg/Lb,c

0.96 (0.49–2.98)

0.93 (0.41–2.1)

1.1 (0.5–3.14)

0.392

1.79 (0.64–3.80)

0.56 (0.22–1.01)

 < 0.001

DASH Index (0–80)

43.86 ± 8.59

43.00 ± 8.44

44.25 ± 8.69

0.505

42.10 ± 8.68

47.59 ± 7.19

0.002

Vegetarian Lifestyle Index (0–14)

7.64 ± 1.58

7.08 ± 1.29

7.89 ± 1.65

0.01

7.40 ± 1.53

8.15 ± 1.58

0.026

HEIFA Score (0–100)

60.04 ± 11.61

60.84 ± 11.73

59.68 ± 11.63

0.647

57.74 ± 11.28

64.94 ± 10.92

0.003

MEDAS Score (0–14)

6.45 ± 2.30

6.45 ± 2.43

6.45 ± 2.26

0.996

6.07 ± 2.09

7.25 ± 2.55

0.016

erMedDiet Score (0–17)

8.30 ± 2.25

8.10 ± 2.12

8.39 ± 2.31

0.547

8.03 ± 2.02

8.88 ± 2.61

0.112

  1. BMI body mass index, DASH Dietary Approach to Stop Hypertension, erMedDIET Predimed-Plus Diet Score, HEIFA Healthy Eating Index for Australian Adults, hsCRP high-sensitivity c reactive protein, Lp-PLA2 lipoprotein-associated phospholipase A2, mg/L, MEDAS, Mediterranean Diet Adherence Screener; milligrams per litre, ng/L, nanograms per litre, nmol/min/mL nanomoles per min per millilitre, PA physical activity, PAF platelet activating factor, SBP systolic blood pressure, SD standard deviation
  2. aIndependent T-test performed P < 0.05 represents significant difference
  3. bMann Whitney U test performed P < 0.05 represents significant difference
  4. cn = 99
Back to article page

Nutrition & Metabolism

ISSN: 1743-7075

Contact us